HORMOSAN
HORMOSAN Pharma GmbH is a Frankfurt-based, Lupin-owned German pharmaceutical company that markets and distributes innovative medications and generics across rare neurology, pain, sexual health, respiratory/inhalation, and general therapeutic areas, serving pharmacies throughout Germany.
- Company typePrivate
- Founded1975
- HeadquartersFrankfurt, Germany
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What HORMOSAN does
HORMOSAN Pharma GmbH is a Frankfurt am Main-based German pharmaceutical company founded in 1975 and operating as a wholly-owned subsidiary of Lupin Limited, the Indian multinational pharmaceutical conglomerate. The company markets and distributes a diversified portfolio of innovative medications and generic pharmaceuticals across five therapeutic focus areas: rare neurological diseases (Myasthenia gravis, Myotonie, Chorea Huntington); pain therapy (migraine, cluster headache, general analgesics); sexual health (contraceptives, HIV/PrEP, erectile dysfunction, hair loss); respiratory diseases (asthma and COPD via inhalation therapy); and a broader generic portfolio. HORMOSAN positions itself as a specialist in underserved therapeutic niches rather than as a commodity generics supplier.
The company holds manufacturer authorization under §13 AMG and wholesale distribution permit under §52a AMG of the German Medicines Act, enabling in-country manufacturing authorization alongside distribution. It differentiates through specific formulations and dosage forms designed to improve patient compliance, supported by an extensive library of patient education materials, brochures, and adherence tools. The company maintains a medical-scientific hotline, customer service team, and HCP-targeted communications via DocCheck-secured professional content channels.
HORMOSAN operates a sales-led, B2B go-to-market model, distributing to pharmacies throughout Germany with a minimum order value of €150 and 30-day payment terms. Beyond its German commercial role, HORMOSAN functions as Lupin Limited's designated pharmacovigilance representative in the European Union, sharing data protection responsibilities with sister company Lupin Europe GmbH at the same Frankfurt address. The company employs 51-100 staff and is led by Managing Directors Thierry Volle, Sunil Makharia, and Peer Seeger.
HORMOSAN firmographics
Firmographics- Name
- HORMOSAN
- Legal name
- Hormosan Pharma GmbH
- Website
- https://hormosan.com
- Company type
- Private
- Founded year
- 1975
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- HORMOSAN Pharma GmbH is a Frankfurt-based, Lupin-owned German pharmaceutical company that markets and distributes innovative medications and generics across rare neurology, pain, sexual health, respiratory/inhalation, and general therapeutic areas, serving pharmacies throughout Germany.
- Ownership category
- akta.pro rank
HORMOSAN industry classification
Industry- Product category
- Generic Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Specialty Care Pharmaceuticals (HLAIAAAB)
- akta.pro secondary industries
- Respiratory & Allergy Pharmaceuticals (HLAIAAAH), Neurology & CNS Specialty Pharmaceuticals (HLAIACAC), Generic Hospital & Institutional Products (HLAIABAL)
Keywords
Where HORMOSAN is headquartered
LocationHeadquarters
- HQ city
- Frankfurt
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
HORMOSAN business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Pharmaceutical Products: Revenue generated from sale of innovative medications and generic pharmaceuticals across therapeutic areas including rare neurological diseases, pain therapy, sexual health, respiratory/inhalation, and general generics.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Minimum order value requirement |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
HORMOSAN product offering
Product offeringCore offering
HORMOSAN Pharma GmbH is a German pharmaceutical company that manufactures and distributes prescription (Rx) medications, combining innovative drugs addressing unmet medical needs with a broad portfolio of high-quality generics. The company specializes in five therapeutic areas: rare neurological diseases (Myasthenia gravis, Myotonie, Chorea Huntington), pain therapy (migraine, cluster headache, analgesics), sexual health (contraceptives, HIV/PrEP, erectile dysfunction, hair loss), respiratory diseases (asthma/COPD inhalation therapy), and general generics, supported by patient education materials and accompanying services.
Product overview
HORMOSAN is a German pharmaceutical company offering a diversified portfolio of innovative medications and generic drugs for acute and chronic diseases. Their core offerings span five therapeutic focus areas: (1) Rare neurological diseases including Myasthenia gravis, myotonias, and Chorea Huntington, (2) Pain therapy including migraine and analgesics, (3) Sexual health covering contraceptives, HIV/PrEP, erectile dysfunction, and hair loss, (4) Respiratory diseases (asthma/COPD), and (5) A comprehensive generic portfolio. The company differentiates through specific formulations and delivery forms to improve patient compliance, combined with extensive patient education materials and support services.
Differentiator
Problem solved
Functional benefit
Products and services
- Seltene Erkrankungen in der Neurologie (Rare Neurological Disease Medications)
Companies that use HORMOSAN
Customer profileSegments6 records
Ideal customer profiles2 records
HORMOSAN technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
HORMOSAN partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Lupin GroupcoreHORMOSAN is a subsidiary company (Ein Unternehmen der LUPIN Gruppe) of Lupin Limited, a major global pharmaceutical company headquartered in India. As part of the Lupin Group, HORMOSAN operates as the European subsidiary focusing on the German market, with joint data responsibility shared between Hormosan Pharma GmbH and Lupin Europe GmbH. Lupin Limited has designated HORMOSAN as its representative for pharmacovigilance activities in the European Union.
Scale indicators1 record
Recent moves5 records
Expansion highlights5 records
HORMOSAN competitors and assessment
Company assessmentDirect peers
- ALIUD Pharma GmbH: Laichingen-based German generics company specializing in cost-effective prescription medications distributed to pharmacies, closely matching HORMOSAN's generics positioning.
- Hexal AG: Germany's largest generics manufacturer (Sandoz/Novartis subsidiary) with broad portfolio including respiratory, neurology, and HIV products. Directly competes with HORMOSAN in German pharmacy generics and specialty categories.
- ratiopharm GmbH (Teva): German generics subsidiary of Teva Pharmaceutical Industries. Comparable to HORMOSAN as a mass-market German generics player with broad therapeutic coverage and pharmacy distribution.
- Aristo Pharma GmbH: Berlin-based German generics and specialty pharmaceutical company with portfolio spanning neurology, pain, respiratory, and other therapeutic areas, distributed through German pharmacies.
- betapharm Arzneimittel GmbH: Augsburg-based German generics manufacturer with broad therapeutic portfolio distributed through German pharmacies, directly comparable to HORMOSAN's generics business.
- Mibe GmbH Arzneimittel: German specialty pharma subsidiary within Dermapharm group focused on branded generics, neurology, and pain therapy products — comparable therapeutic mix and German pharmacy distribution model.
- Stada Arzneimittel AG: Major German generics and specialty pharmaceutical company headquartered in Bad Vilbel. Directly comparable as a mid-to-large German pharma player with a diversified generics and specialty portfolio across similar therapeutic areas, serving the same pharmacy distribution channel.
- Heumann Pharma GmbH & Co. Generica KG: Nuremberg-based German generics manufacturer offering affordable alternatives across therapeutic categories, distributing through the same German pharmacy channel as HORMOSAN.
- Dermapharm Holding SE: German mid-cap pharmaceutical company with focus on branded generics and specialty products including dermatology, neurology, and pain — operates a similar specialty/generics hybrid model.
Broad incumbents
- AbbVie Deutschland GmbH & Co. KG: German subsidiary of global biopharma major; while broader and more diversified, overlaps with HORMOSAN in neurology (e.g., central nervous system products) and operates in the same German Rx market.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
HORMOSAN social profiles
Digital presenceHORMOSAN compliance and trust
Trust signalCompliance1 record
HORMOSAN financial estimates
Financial estimateRevenue estimate
Valuation estimate
HORMOSAN leadership team
Management profileNumber of profiles
Profiles6 records
HORMOSAN funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
HORMOSAN M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about HORMOSAN
What does HORMOSAN do?
HORMOSAN Pharma GmbH is a German pharmaceutical company that manufactures and distributes prescription (Rx) medications, combining innovative drugs addressing unmet medical needs with a broad portfolio of high-quality generics. The company specializes in five therapeutic areas: rare neurological diseases (Myasthenia gravis, Myotonie, Chorea Huntington), pain therapy (migraine, cluster headache, analgesics), sexual health (contraceptives, HIV/PrEP, erectile dysfunction, hair loss), respiratory diseases (asthma/COPD inhalation therapy), and general generics, supported by patient education materials and accompanying services.
Is HORMOSAN a public or private company?
HORMOSAN is a private company. It is classified as corporate owned and is currently operating.
When was HORMOSAN founded?
HORMOSAN was founded in 1975. It employs 51 to 100 people.
Where is HORMOSAN based?
HORMOSAN is headquartered in Frankfurt, Germany, in the Europe region.
How does HORMOSAN make money?
One revenue line is on record: pharmaceutical Products.
Who are HORMOSAN's main competitors?
Direct peers on record are ALIUD Pharma GmbH, Hexal AG, ratiopharm GmbH (Teva), Aristo Pharma GmbH, betapharm Arzneimittel GmbH, Mibe GmbH Arzneimittel, Stada Arzneimittel AG, Heumann Pharma GmbH & Co. Generica KG and Dermapharm Holding SE. AbbVie Deutschland GmbH & Co. KG is listed as a broad incumbent.
Does HORMOSAN have an API?
No public API is recorded for HORMOSAN.
What industry is HORMOSAN in?
HORMOSAN's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals, with a secondary code of HLAIAAAH, Respiratory & Allergy Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.